Sleeping pill ban 'a surprise'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.THE SLEEPING pill Halcion was finally banned in the UK yesterday when the Government's Licensing Authority revoked all licences for the drug whose generic name is triazolam, writes Celia Hall.
The decision has surprised the drug's makers, Upjohn, as a recent Department of Health review committee found in its favour. Yesterday Upjohn released details of this report.
Halcion first became available in the UK in 1979. It was a popular sleeping pill because its short 'life' in the body, meant that a morning-after hangover could be avoided. In 1988 world-wide sales reached pounds 265m.
But other side effects were reported including potentially dangerous personality changes. Investigations by government agencies began in this country after an American court case revealed errors in a report of a clinical trial produced by Upjohn.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments